Resources Contact Us Home
Binding peptides for carcinoembryonic antigen (CEA)

Image Number 5 for United States Patent #7438890.

The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.

  Recently Added Patents
Maize hybrid X95C382
Configuration method and system of complex network and configuration and management module of server resources
Electromagnetic probe for measuring properties of a subsurface formation
Water purification using energy from a steam-hydrocarbon reforming process
Touchscreen with Z-velocity enhancement
Catalytic pyrolysis using UZM-44 aluminosilicate zeolite
Hybrid CMOS nanowire mesh device and PDSOI device
  Randomly Featured Patents
Dual-stage filter with feedback
Physically small antenna elements and antennas based thereon
Method of operating a pair of burners and apparatus for use in the method
Device for the translational driving of a piston for the distribution of pasty products
Beater mill having at least one vertically or obliquely extending cylindrical milling chamber
Sensitivity controlled dual input fire detector
Magnetically coupled pump with a bipartite separating pot
Sulfate of 5,6,7,8-tetrahydro-L-erythro-biopterin and process for preparing the same
Expandable stent apparatus and method
Clutch structure for manual hoists